Meeting Neurodegenerative Disease Head-On with Emerging Drug Discovery Strategies
Chronic neurodegenerative diseases encompass a variety of progressive conditions that affect neurons, including Huntington’s disease, Parkinson’s disease, Alzheimer’s disease, and other forms of dementia. They are among the most common and challenging central nervous system (CNS) diseases. “Many companies had stopped their research program into neurodegenerative diseases, but now sophisticated technology advances have became more broadly available” says Kris Rutten, Director at WuXi AppTec. “All of these tools build confidence when developing a drug candidate and are paving a new way of doing CNS drug development.”
WuXi AppTec - Meeting Neurodegenerative Disease Head-On with Emerging Drug Discovery Strategies
